DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Harrison CN, Schaap N, Vannucchi AM. et al.
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: an updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure.
Am J Hematol 2020;
95 (06) 594-603
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.